Natrilix Retard (Indapamide)

Indapamide, the active ingredient in Natrilix Retard, is a thiazide‑like diuretic presented as an oral tablet for oral use. It is indicated for adults with essential hypertension and for the management of edema associated with congestive heart failure, offering a long‑acting therapeutic effect.

GNH USA supplies Natrilix Retard as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing, regulatory support and consistent quality for global healthcare providers.

Indapamide works within the renal‑vascular system to control blood pressure and fluid balance, making it useful for several cardiovascular conditions. - Hypertension: lowers systolic and diastolic blood pressure in patients with essential hypertension. - Edema associated with congestive heart failure: promotes diuresis to reduce fluid overload and improve symptoms. - Primary prevention of cardiovascular events: contributes to risk reduction when used as part of a comprehensive antihypertensive regimen.

Indapamide may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Electrolyte imbalance: hypokalemia, hyponatremia, or hyperuricemia. - Metabolic changes: mild increase in blood glucose or cholesterol. - Gastrointestinal discomfort: nausea, abdominal cramps, or dyspepsia. - Dizziness or headache, especially after the first dose.

Serious or Rare Side Effects: - Severe electrolyte disturbances leading to arrhythmias. - Acute renal failure in susceptible individuals. - Allergic reactions such as rash, pruritus, or angioedema. - Pancreatitis or severe hepatic dysfunction (very rare).

Before initiating therapy, clinicians should assess patient history and laboratory values. - Renal function: evaluate serum creatinine and adjust if impairment is present. - Electrolytes: monitor potassium, sodium and uric acid levels regularly. - Diabetes: watch for possible hyperglycaemia, especially in insulin‑dependent patients. - Concomitant antihypertensives: avoid excessive blood pressure fall. - Store at ambient temperature: keep below 25 °C, retain in original packaging and protect from moisture.

Indapamide can alter the pharmacodynamics of several co‑administered drugs.

Major Interactions (Avoid): - Lithium: increased lithium levels may cause toxicity. - NSAIDs (e.g., ibuprofen, naproxen): may reduce diuretic efficacy and impair renal function.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: enhanced hypotensive effect; monitor blood pressure. - Antidiabetic agents: risk of hypoglycaemia; adjust glucose monitoring. - Anticoagulants (e.g., warfarin): potential increase in INR; check coagulation parameters.